Loading
PDBj
✖
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

22BN

Crystal structure of ZNF384-r ZF3-4

Summary for 22BN
Entry DOI10.2210/pdb22bn/pdb
DescriptorIsoform 2 of Zinc finger protein 384, ZINC ION, PHOSPHATE ION, ... (5 entities in total)
Functional Keywordsb-cell acute lymphoblastic leukemia (b-all), oncogenic driver, znf384-r, id2, targeted therapy, transcription
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight28569.21
Authors
Wang, J.F.,Meng, G.Y. (deposition date: 2026-01-05, release date: 2026-11-18)
Primary citationWang, J.,Deng, X.,Yu, X.,Zhang, H.,Huang, H.,Ma, X.,Li, Z.,Jin, J.,Jing, D.,Wang, H.,Meng, G.
Structures and therapeutic mechanisms in ZNF384-r B-cell acute lymphoblastic leukemia.
Int.J.Biol.Macromol., :155061-155061, 2026
Cited by
PubMed Abstract: ZNF384 gene rearrangement (ZNF384-r) is one of the major genetic lesion in 4% B-cell acute lymphoblastic leukemia (B-ALL) patients. However, the exact pathogenic mechanism leading to the leukemia outbreak remains elusive. Here, we determined the crystal structure of the ZNF384 zinc finger (ZF) domains 3-4 (2.0 Å). This helped to obtain the model ZNF384-DNA complex by AlphaFold 3, SAXS and X-ray crystallography. Site directed mutagenesis identified key residues Q68 in ZF3 and Q98 in ZF4 that were essential for transcriptional activity. Clinical characteristics of 10 new cases of ZNF384-r B-ALL were reported and integrated multi-omics profiling identified ID2 as a ZNF384-r-dependent target gene that was frequently associated with poor prognosis. Abnormal ID2 expression delineated a clinically adverse subgroup characterized by more severe differentiation arrest and immunosuppressive signature. Supportively, targeting ID2 in ZNF384-r cells induced mitochondrial apoptosis and effectively suppressed leukemia progression in patient derived xenograft (PDX) mice. Altogether, this study not only revealed the DNA engagement mechanism in oncogenic ZNF384-r fusion, but also highlighted ID2 as a promising therapeutic target in B-ALL.
PubMed: 42950930
DOI: 10.1016/j.ijbiomac.2026.155061
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

263157

PDB entries from 2026-11-18

PDB statisticsPDBj update infoContact PDBjnumon